Subscribe to Newsletter

Content by Mark Hillen:

Business & Profession Other

The Road to Hell Is Paved with Good Intentions

| Mark Hillen

Maurice Saatchi wants new legislation to free British doctors from fear of litigation in the pursuit of innovation. Others view it as a charlatan’s charter

Business & Profession Business and Innovation

The Innovation Awards 2014

| Mark Hillen

Showcasing the greatest ophthalmic advances of the year

Business & Profession Business and Innovation

The Top 5 Lessons from Ophthalmology Futures 2014

| Mark Hillen

The world’s top clinicians and captains of industry came together in London last month to discuss the future of ophthalmology. Here’s what we learned

Subspecialties Retina

Benchmarking VMA/VMT

| Mark Hillen

What does analysis of the last five years of the literature on vitreomacular traction/ adhesion tell us about the priorities of the field and the major contributors to it?

Subspecialties Retina

A Glut of Glucose? Gibberish!

| Mark Hillen

Statins may interfere with glucose metabolism, and their use might be damaging the diabetic eye. Or perhaps not...

Subspecialties Retina

VIIP: A Space Odyssey

| Mark Hillen

Many astronauts develop eye problems in space. NASA wants to know why, so they’ve established the Vision Impairment and Intracranial Pressure (VIIP) program.

Subspecialties Retina

Choroid Cartography

| Mark Hillen

Why are certain regions of the choroid more prone to disease than others? To answer that, you need proteomics

Subspecialties Cataract

IOL Clinical Trials

| Mark Hillen

One of the most commonly performed surgical procedures in the world is cataract surgery

Business & Profession Professional Development

Being Engaged

| Mark Hillen

The Ophthalmologist is one year old. We promised to tell you ophthalmology’s most engaging stories, and we’ve traveled the world to do so.

Subspecialties Retina

A Retinoid a Day Keeps The Blindness Away

| Mark Hillen

Oral replacement therapy of the retinoid intermediate that fails to form in some types of Leber congenital amaurosis shows significant promise in an early-phase clinical trial

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: